Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Avail (AVAIL) vs Immunefi (IMU) Price & Performance

Avail
Immunefi

Price performance

Price movement over the last 24 hours

Key statistics

Avail vs Immunefi — how do they compare? Avail trades at Rp51.05 (market cap Rp200,14M, Rp8,7M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Avail is far larger — about 7.4× Immunefi's market cap, and Immunefi's supply is capped (873,4M / 10B IMU (9%)) while Avail's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Avail for 18 Days and Immunefi for 5 Days on average.

AVAILIMU
Market Cap
Rp200,14MRp27,03M
Volume (24h)
Rp8,7MRp39,91M
Circulating Supply
3,9B AVAIL873,4M / 10B IMU (9%)
Typical Hold Time
18 Days5 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Avail

Avail is trading at Rp52.169 with a market cap of Rp203.92M, showing a bearish technical signal driven by moving averages. The asset has a short hold time of 18 days, indicating trader impatience. No major protocol updates or ecosystem developments are noted recently. Support is firm at Rp51 and Rp52, while resistance lies at Rp52 and Rp53, creating a tight trading range.

Overall outlook is cautious due to bearish momentum and low liquidity. Key opportunities include potential rebounds from support levels, but risks involve high volatility and limited market depth. Investors should monitor for any network updates or exchange listings that could improve sentiment.

Immunefi

Immunefi token shows limited market activity with a modest market cap of Rp27,03M and low circulation rate of 9%. The asset demonstrates minimal trading volume and network engagement, with token holders maintaining short 5-day holding periods. Recent coverage appears misaligned with the cryptocurrency's actual blockchain metrics, suggesting potential entity confusion.

Outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunities include potential network growth, while major risks involve low adoption, regulatory uncertainty, and market volatility. Investors should monitor on-chain metrics for signs of genuine protocol activity.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

AVAIL
20% Buy80% Sell
Avg holding period · 18 Days
IMU

No sentiment data available yet.

About Avail

Avail is a blockchain project designed to address the complexities of data availability and interoperability within the decentralized ecosystem. As a modular blockchain base layer, Avail provides a common data availability layer that facilitates seamless interaction between different blockchains. This foundational layer is crucial for next-generation, trust-minimized applications, enabling them to operate efficiently and securely.

Read more on AVAIL

About Immunefi

Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.

Read more on IMU